Trident Texofab Limited has submitted Earnings Presentation for the quarter and half year ended on September 30, 2020(Q2FY21/H1FY21). Kindly take the above on record. Thank you.
The Board of Directors approved the Consolidated and Standalone - Un-Audited Financial Results for the Quarter and half year ended September 30, 2020 as reviewed and recommended by the Audit Committee at its meeting held today. In this connection please find attached herewith: a) Presentation on the operation and financial results of the Company in terms of Regulation 46 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
The Board of Directors approved the Consolidated and Standalone - Un-Audited Financial Results for the Quarter and half year ended September 30, 2020 as reviewed and recommended by the Audit Committee at its meeting held today. In this connection please find attached herewith: a) Presentation on the operation and financial results of the Company in terms of Regulation 46 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015